Open AccessB04: COMBINATION OF SUBCUTANEOUS TECLISTAMAB WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM A PHASE 1B MULTICOHORT STUDY
Author(s) -
RodriguezOtero P,
Dholaria B,
Askari E,
Reece D,
Donk N,
Chari A,
Goldschmidt H,
Krishnan A,
Martin T,
Mateos M,
Morillo D,
Rodriguez C,
Rosinol L,
SanMiguel J,
Balari A,
Wäsch R,
Weisel K,
Verona R,
Lin S,
Prior T,
Wade M,
Weiss B,
Goldberg J,
Oriol A,
Hari P
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000829556.56345.01
Subject(s) - medicine , daratumumab , oncology , tec , adverse effect , gastroenterology , multiple myeloma , bortezomib , ionosphere , physics , astronomy